Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-22-000038

Director acquired 22,708 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
O'Meara Maeve Director 2022-11-17 Grant or award +22,708 42,700 D: show line 1 in the form
Loading xslF345X03/edgardoc.xml…